About Specific Technologies
Specific Technologies is a company based in San Francisco (United States) founded in 2009 by Paul Rhodes and Ray Martino was acquired by BioMerieux in April 2022.. Specific Technologies has raised $30 million across 2 funding rounds from investors including BioMerieux and Telegraph Hill Partners. Specific Technologies operates in a competitive market with competitors including Cepheid, Day Zero Diagnostics, SeLux Diagnostics, SpinDiag and MicrobeDx, among others.
- Headquarter San Francisco, United States
- Founders Paul Rhodes, Ray Martino
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30 M (USD)
in 2 rounds
-
Latest Funding Round
$17.5 M (USD), Series A
Feb 10, 2020
-
Investors
BioMerieux
& 1 more
-
Employee Count
Employee Count
-
Acquired by
BioMerieux
(Apr 12, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Specific Technologies
Specific Technologies has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $17.5 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $17.5M
-
First Round
First Round
(06 Sep 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Series A - Specific Technologies | Valuation |
investors |
|
| Sep, 2019 | Amount | Series B - Specific Technologies | Valuation | Telegraph Hill Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Specific Technologies
Specific Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BioMerieux and Telegraph Hill Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Developer of diagnostics devices for multiple health purposes
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Specific Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Specific Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Specific Technologies Comparisons
Competitors of Specific Technologies
Specific Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Day Zero Diagnostics, SeLux Diagnostics, SpinDiag and MicrobeDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of alternatives to traditional ELISA assays
|
|
| domain | founded_year | HQ Location |
Point-of-care systems for screening drug-resistant pathogens are developed.
|
|
| domain | founded_year | HQ Location |
Provider of the solutions for the detection of antibiotic susceptibility in urinary tract infections
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Specific Technologies
Frequently Asked Questions about Specific Technologies
When was Specific Technologies founded?
Specific Technologies was founded in 2009 and raised its 1st funding round 10 years after it was founded.
Where is Specific Technologies located?
Specific Technologies is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Specific Technologies?
Paul Rhodes is the current CEO of Specific Technologies. They have also founded this company.
Is Specific Technologies a funded company?
Specific Technologies is a funded company, having raised a total of $30M across 2 funding rounds to date. The company's 1st funding round was a Series B of $12.5M, raised on Sep 06, 2019.
What does Specific Technologies do?
Specific Technologies was founded in 2009 and is based in San Francisco, United States. Operations focus on the diagnostics sector, where blood infection detection and antibiotic susceptibility testing are conducted. Two products, Reveal AST and Reveal ID, are offered, both supporting susceptibility assessments. Leadership includes co-founder and CEO Paul Rhodes, alongside founder Ray Martino. Services target healthcare applications in infection management.
Who are the top competitors of Specific Technologies?
Specific Technologies's top competitors include Cepheid, Day Zero Diagnostics and SeLux Diagnostics.
Who are Specific Technologies's investors?
Specific Technologies has 2 investors. Key investors include BioMerieux, and Telegraph Hill Partners.